Jun 27, 2026 Log in

News

4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.

Citation-Grade Primary-source linked Schema.org verified NQ 77 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Jun 27, 2026 9:00 AM ・ Updated Jul 8, 2026 10:02 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.

Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/v1/opendata/t187ap04_L#4164-2026-06-27-ee3e5114 Distributor: PR Times
Published: Jun 27, 2026

Announcement Date: June 27, 2026 Statement Date: June 26, 2026 Statement Time: 16:24:52 Company Code: 4164 Company Name: Chengye Medical

Subject: Announcement of Dividend Distribution Resolved by Shareholders' Meeting of Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.

Applicable Clause: Item 14 Event Date: June 26, 2026

Details: 1. Board Resolution Date: June 26, 2026 2. Type and Amount of Dividend Distribution: Cash dividend of TWD 77,475,270. 3. Other Matters to be Disclosed: None

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Jun 27, 2026 9:00 AM — Distributor PR Times
Collected　Jun 27, 2026 3:23 PM
AI structured & analyzed　Jun 27, 2026 3:25 PM
Desk-reviewed & published　Jun 27, 2026 9:00 AM

FAQ

What is Chengye Medical?

A Taiwan-based healthcare company operating through subsidiaries in pharmaceuticals and wellness.

When will the dividend be paid?

The payment date has not been announced, but typically occurs within 1–2 months after resolution.

What does Fu Kang Active Pharmaceutical do?

It focuses on pharmaceutical development and distribution in Taiwan’s domestic market.

Does this announcement affect investment decisions?

Stable dividends signal financial health, making it a positive indicator for long-term investors.

Where is Chengye Medical listed?

It is listed on the Taiwan Stock Exchange under ticker 4164.

Cite this article — HOW TO CITE

Washin AI News Desk“4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.”AI News by Washin Village（和心村）, Jun 27, 2026. https://aeo.idaeo.ai/ai/openapi-twse-com-tw/en/news/2026-06-27-4164-%E6%89%BF%E6%A5%AD%E9%86%AB

AI CRAWLER ACTIVITY

as of Aug 16, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

3065k

last Aug 16, 2026

GPTBot

bot_visits_summary

2140k

last Aug 16, 2026

Bingbot

bot_visits_summary

812k

last Aug 16, 2026

Amazonbot

bot_visits_summary

584k

last Aug 16, 2026

Meta AI

bot_visits_summary

544k

last Aug 16, 2026

ClaudeBot

bot_visits_summary

411k

last Aug 16, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← openapi-twse-com-tw Back to newsroom (21544)

Copied